Study of Sexuality in Parkinson Disease (Sex-PD)
|ClinicalTrials.gov Identifier: NCT01878409|
Recruitment Status : Completed
First Posted : June 17, 2013
Last Update Posted : June 17, 2013
|Condition or disease|
Because there is limited literature on sexual function in Parkinson disease, in this study, we examined sexual functioning in a large groups of patients with idiopathic Parkinson Disease compared with healthy subjects in the Italian community. To assess sexual function in PD we used the Brief Index of Sexual Functioning [(BISF-M for man; BISF-W for woman), the International Index of Erectile Function (IIEF) and the Female Sexual Function Index (FSFI). Participants were also assessed by the Beck Depression Inventory (BDI).
This study aimed to provide a thorough epidemiological description of sexual dysfunction in Parkinson's disease. The knowledge of sexual function in PD might help to plan effective interventionist measures and ultimately to optimize patient's and the partner's quality of life.
Parkinson patients (aged 40-80) and 123 healthy controls (aged 40-80) will be recruited from four Italian Movement Disorders Clinics.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||244 participants|
|Observational Model:||Case Control|
|Target Follow-Up Duration:||1 Day|
|Official Title:||Study of Sexuality in Parkinson Disease|
|Study Start Date :||January 2010|
|Primary Completion Date :||November 2012|
|Study Completion Date :||November 2012|
Patients with Parkinson Disease
- BISF [ Time Frame: Baseline ]Brief Index of Sexual Functioning (BISF-M for man; BISF-W for woman)International Index of Erectile Function (IIEF) Female Sexual Function Index (FSFI)
- BDI [ Time Frame: Baseline ]Beck Depression Inventory (BDI) is a 21.-item self report inventory, for measuring the severity of depression in clinical and nonclinical populations.
- PDQ8 [ Time Frame: Baseline ]Parkinson' Disease Questionnaire-8 (PDQ- 8) is a self completion PRO designed to address aspects of functioning and well-being for those affected by Parkinson's disease.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01878409
|Fondazione IRCCS Ca' Granda|
|Milano, Italy, 20122|
|Principal Investigator:||Alberto Priori, MD,PhD||Fondazione IRCCS Ca' Granda, Università di Milano|